搜索筛选:
搜索耗时4.1481秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
类      型:
[会议论文] 作者:yuejiao Zhong, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:yuejiao Zhong, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:yuejiao Zhong, 来源:2019中国肿瘤学大会 年份:2019
Objective The chemotherapy of Primary central nervous lymphoma(PCNSL)is single and limited.High-dose methotrexate(HD-MTX)intravenous chemotherapy is still the most effective method for treatment of PC...
[会议论文] 作者:Xiaoyou Li,Jianzhong Wu,Haixia Cao,Yuejiao Zhong,Jianqiu Wu,Jifeng Feng, 来源:第六届中国肿瘤内科大会 年份:2012
[会议论文] 作者:Xiaoyou Li,Jianzhong Wu,Haixia Cao,Yuejiao Zhong,Jianqiu Wu,Jifeng Feng, 来源:第六届中国肿瘤内科大会 年份:2012
Background: The sensitivity of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has been found to be associated with mutations in the tyrosine kinase domain of EG...
[会议论文] 作者:Yuejiao Zhong,Qin Zhou,Pingping Wu,Huayun Zhu,Xiaofeng Sun,Jia Chen,Lingxiang Chen, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
  Objective: To observe the PFS (Progression Free Survival) could be extended inadvanced non-small cell lung cancer patients with gradual progression after fa...
[会议论文] 作者:Yuejiao Zhong,Xiaofeng Sun,Pingping Wu,Qin Zhou,Huayun Zhu,Lingxiang Chen,Jia Chen, 来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
Objective: To observe the PFS (Progression Free Survival) could be extended inadvanced non-small cell lung cancer patients with gradual progression after failure of EGFR tyrosine kinase inhibitors the...
相关搜索: